Department of Medical Biochemistry and Pharmacology, 60498 Haukeland University Hospital , Bergen, Norway.
Department of Heart Disease, 60498 Haukeland University Hospital , Bergen, Norway.
Clin Chem Lab Med. 2024 Apr 4;62(10):2030-2036. doi: 10.1515/cclm-2024-0154. Print 2024 Sep 25.
Secretoneurin (SN) is a novel cardiac biomarker that associates with the risk of mortality and dysfunctional cardiomyocyte Ca handling in heart failure patients. Reference intervals for SN are unknown.
SN was measured with a CE-marked ELISA in healthy community dwellers from the fourth wave of the Trøndelag Health Study (HUNT4) conducted in 2017-2019. The common, sex and age specific 90th, 95th, 97.5th and 99th percentiles were calculated using the non-parametric method and outlier exclusion according to the Reed test. The applicability of sex and age specific reference intervals were investigated using Harris and Boyd test. We also estimated the percentiles in a subset with normal findings on echocardiographic screening.
The total cohort included 887 persons (56.4 % women). After echocardiographic screening 122 persons were excluded, leaving a total of 765 persons (57.8 % women). The 97.5th percentile (95 % CI in brackets) of SN was 59.7 (57.5-62.1) pmol/L in the total population and 58.6 (57.1-62.1) pmol/L after echocardiography screening. In general, slightly higher percentiles were found in women and elderly participants, but less than 4 % in these subgroups had concentrations deviating from the common 97.5th percentile. Low BMI or eGFR was also associated with higher concentrations of SN.
Upper reference limits for SN were similar amongst healthy adult community dwellers regardless of prescreening including cardiac echocardiography or not. Women and elderly showed higher concentrations of SN, but the differences were not sufficiently large to justify age and sex stratified upper reference limits.
分泌素(SN)是一种新型的心脏生物标志物,与心力衰竭患者的死亡率和功能失调的心肌细胞钙处理风险相关。SN 的参考区间尚不清楚。
在 2017-2019 年进行的第四次特隆德拉格健康研究(HUNT4)中,使用经过 CE 标记的 ELISA 在健康的社区居民中测量 SN。使用非参数方法和根据 Reed 检验排除异常值计算常见、性别和年龄特异的第 90、95、97.5 和 99 百分位数。使用 Harris 和 Boyd 检验研究性别和年龄特异参考区间的适用性。我们还在超声心动图筛查正常发现的亚组中估计了百分位数。
总队列包括 887 人(56.4%为女性)。经过超声心动图筛查后,有 122 人被排除,共有 765 人(57.8%为女性)。SN 的第 97.5 百分位数(括号内为 95%置信区间)在总人群中为 59.7(57.5-62.1)pmol/L,在超声心动图筛查后为 58.6(57.1-62.1)pmol/L。一般来说,女性和老年参与者的百分位数略高,但这些亚组中只有不到 4%的人的浓度偏离了常见的第 97.5 百分位数。低 BMI 或 eGFR 也与 SN 浓度升高相关。
无论是否包括心脏超声筛查,健康成年社区居民的 SN 上参考限相似。女性和老年人的 SN 浓度较高,但差异不足以支持按年龄和性别分层的上参考限。